Pre-exposure vaccination in the high-risk population is crucial in controlling mpox resurgence in Canada

Authors

Woldegebriel Assefa Woldegerima (ORCID: https://orcid.org/0000-0002-0336-7831)
Jude Dzevela Kong (ORCID: https://orcid.org/0000-0002-7557-5672)
Andrew Omame (ORCID: https://orcid.org/0000-0002-1252-1650)
Sarafa A. Iyaniwura (ORCID: https://orcid.org/0000-0002-8854-2335)
Qing Kai Han (ORCID: https://orcid.org/0000-0001-9670-144X)
Nicola Luigi Bragazzi (ORCID: https://orcid.org/0000-0001-8409-868X)
Xiaoying Wang (ORCID: https://orcid.org/0009-0009-4607-7170)
A. Vimala Ebenezer

University of Parma (IT)
UNESCO (FR)
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
Federal University of Technology Owerri (NG)
York University (CA)
Sol Plaatje University (ZA)
Fred Hutch Cancer Center (US)
Response Biomedical (Canada) (CA)
Artificial Intelligence in Medicine (Canada) (CA)
Trent University (CA)
Mekelle University (ET)
Saarland University (DE)